Tripodi, D.; Dominici, R.; Sacco, D.; Santorelli, G.; Rivera, R.; Acquaviva, S.; Marchisio, M.; Brambilla, P.; Battini, G.; Leoni, V. Antibody Response after 3-Dose Booster against SARS-CoV-2 MRNA Vaccine in Kidney Transplant Recipients. Vaccines 2024, 12, 264, doi:10.3390/vaccines12030264.
Tripodi, D.; Dominici, R.; Sacco, D.; Santorelli, G.; Rivera, R.; Acquaviva, S.; Marchisio, M.; Brambilla, P.; Battini, G.; Leoni, V. Antibody Response after 3-Dose Booster against SARS-CoV-2 MRNA Vaccine in Kidney Transplant Recipients. Vaccines 2024, 12, 264, doi:10.3390/vaccines12030264.
Tripodi, D.; Dominici, R.; Sacco, D.; Santorelli, G.; Rivera, R.; Acquaviva, S.; Marchisio, M.; Brambilla, P.; Battini, G.; Leoni, V. Antibody Response after 3-Dose Booster against SARS-CoV-2 MRNA Vaccine in Kidney Transplant Recipients. Vaccines 2024, 12, 264, doi:10.3390/vaccines12030264.
Tripodi, D.; Dominici, R.; Sacco, D.; Santorelli, G.; Rivera, R.; Acquaviva, S.; Marchisio, M.; Brambilla, P.; Battini, G.; Leoni, V. Antibody Response after 3-Dose Booster against SARS-CoV-2 MRNA Vaccine in Kidney Transplant Recipients. Vaccines 2024, 12, 264, doi:10.3390/vaccines12030264.
Abstract
The Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated with a high rate of mortality in kidney transplant recipients (KTRs). The current vaccine strategy for KTRs seems to be unable to provide effective protection against coronavirus disease 2019 (COVID-19) [2] and the occurrence of severe COVID-19 in some vaccinated KTRs suggested a lack of immunity. We analized here the antibody response in a group of 32 kidney transplant recipients (KTR) followed at the Nephrology and Dialysis unit of the Hospital Pio XI of Desio, Italy, compared with a group of 23 healthy workers classified as Late responders (HCW-LR) (10 males age 27-62) and 13 females (age 46-64). We observed that the patients need additional vaccine boosters due to their immunocompromised status and therapy to protect them from infections related to viral variants, in accordance with the literature.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.